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Introduction
Diabetes mellitus is a chronic, insidious disease that
can affect any organ or system of the body. One of the
problems associated with this condition is infection.
Although the prevalences of infection among diabetic
and non-diabetic subjects are similar, the intensity of
infection is being more severe and the response to
therapy slow in diabetic patients.
One of the complications experienced by diabetic
patients is resistant and recurrent infections. Some
believe that the condition is caused by malfunctioning
leucocytes, especially in the presence of uncontrolled
blood glucose levels [1–3]. Among the infections, vaginal
inflammation or infection, especially fungal vaginitis, is
more disturbing in severe hyperglycemic conditions [4].
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SUMMARY
Objective: One of the problems of women with diabetes is resistant vulvovaginitis, which is related to some factors
such as hyperglycemia, allergy and atopy. One of the most common pathogens associated with this condition 
is Candida albicans. Thus, most physicians begin antifungal therapy at the patient’s first visit, even without para-
clinical findings. We aimed to determine the prevalence of Candida vulvovaginitis and factors that cause diabetic
women to be prone to this infection.
Materials and Methods: This descriptive, analytic cross-sectional study was performed in 160 nonpregnant
diabetic women who visited the diabetes clinic of Shariati Hospital in Tehran, Iran from 2002 to 2005. The fasting
blood sugar, 2-hour postprandial blood sugar, and glycosylated hemoglobin were measured, and a culture of
the vaginal discharge was obtained. Statistical analysis was performed using Fisher’s exact test.
Results: Seventy-one percent of the women had clinical vaginitis (fungal or bacterial), and 12.5% (20/160) had
Candida vaginitis. Microscopic findings for Candida were positive in 12 patients, of whom two had Candida vaginitis.
The prevalence of Candida vaginitis together with positive culture was 2.6% (4/160). After including the 10 patients
with positive Candida culture together with other clinical vaginitis, the overall prevalence of Candida vaginitis
based on positive culture was 8.8% (14/160). There was a significant statistical difference between either mean
fasting blood sugar or educational level and infectious vaginal culture. There were no significant associations
between positive culture and age, glycosylated hemoglobin, history of allergy, genital hygiene, occupation, kind
of treatment, and type or duration of diabetes.
Conclusion: We suggest that in the case of clinical vaginitis, especially Candida vulvovaginitis, culture of vaginal
discharge should be warranted even if there is a positive smear. [Taiwan J Obstet Gynecol 2007;46(2):399–404]
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■ ORIGINAL ARTICLE ■
The most common etiologic agent for this infection
is the yeast (fungal) organism, usually Candida [5–9].
Therefore, most gynecologists begin antifungal ther-
apy at the patient’s first visit, even without a culture of
vaginal discharge [5]. Others believe that a specimen
should be taken in resistant or recurrent infections for
vaginal culture during future visits [5]. In a study by
Eckert et al [6], Candida was detected in 28% of cul-
tures of vaginal discharge obtained during the initial
visit of women with vaginitis; the remaining cultures
were for other organisms, such as sexually transmitted
organisms. The authors believed that the causes of
recurrent disease or resistance to therapy were false
diagnosis of the pathogenic organism and unsuitable
treatment [6]. On the other hand, even when correct
diagnosis had been made, background factors, especially
those associated with systemic diseases like diabetes
mellitus, caused treatment failure [4,7]. Researchers
have stressed the importance of personal hygiene, his-
tory of infections and allergic diseases of the upper res-
piratory tract (nose, sinuses), and atopic dermatitis 
in the subject or the relative(s) in recurrent diseases or
resistance to therapy [8]. They believed that effective
steps could be taken to successfully treat this condi-
tion by preventing and controlling or eliminating back-
ground factors. In this study, we aimed to determine
the prevalence of Candida vaginitis in Iranian women
with diabetes mellitus who attended the diabetes clinic
of Shariati Hospital in Tehran during a 3-year period
and the relationship between vulvovaginal candidiasis
and its influencing factors.
Materials and Methods
This descriptive, analytic cross-sectional study was per-
formed in all diabetic women who visited the diabetes
clinic of Shariati Hospital in Tehran from 2002–2005
and were enrolled in the study after signing the
informed consent form.
Each participant had to have proven diabetes 3
months previously. Exclusion criteria included lack of
desire to participate in the study or pregnancy. All sub-
jects were asked to fill out prepared questionnaires on
demographic characteristics, type of diabetes mellitus,
duration and type of its treatment, past history of allergy,
methods of washing underwear (detergents, heat, etc)
and voiding after sexual intercourse, and vaginal ex-
amination was done for each participant by a general
physician. Also, concentrations of fasting blood sugar,
2-hour postprandial blood sugar and glycosylated
hemoglobin were measured, and cultures of vaginal
discharge were performed.
Definitions
Vaginitis is the infection or inflammation of the external
genital tract (vagina) and is caused by various organ-
isms. Presence of disturbing clinical manifestations, such
as burning sensation, itching and vaginal discharge, are
inadequate for definite diagnosis of Candida vaginitis.
In order to determine the organism, especially in recur-
rent Candida vaginitis, it is advisable to obtain a history,
perform microscopic examination with 10–20% potas-
sium hydroxide or 10% normal saline, and perform sub-
sequent culture of vaginal discharge [6]. According to
some studies, Candida was found in only 28% of all cases
with positive clinical signs of Candida vaginitis. Therefore,
the best diagnostic test, on which most researchers,
gynecologists and midwives agree on, is culture of vagi-
nal discharge. In this way, it is possible to differentiate
between the different infecting organisms, especially
those causing sexually transmitted diseases, thereby
preventing treatment failure.
Laboratory methods
All vaginal discharge specimens (for assessment with
or without 10–20% potassium hydroxide or 10% nor-
mal saline and culture of vaginal discharge) were sent
to the Noor Laboratory. The culture media used were
eosin-methylene blue agar for Gram-negative bacilli,
Sabouraud dextrose agar for yeasts, and blood agar
for fungi and bacteria. All media were produced by
Merck (Darmstadt, Germany). Fasting blood sugar, 
2-hour postprandial blood sugar and glycosylated
hemoglobin were estimated in the hormone labora-
tory of the Endocrinology Research Center of Shariati
Hospital.
Written consent was obtained from all patients. This
study was approved by the Medical Ethics Committee
of the Deputy of Research affiliated to the Ministry of
Health and Medical Education. After a data bank had
been designed, data entered into the computer were
analyzed using Fisher’s exact test (SPSS version 11.5).
A p value of ≤ 0.05 was considered to be statistically
significant.
Results
A total of 160 women with diabetes mellitus (mean
age, 51 ± 10 years; age range, 16–75 years) were
enrolled. Ninety-four percent of the patients had type
II diabetes mellitus and the remaining had type I.
Seventy-five percent of the participants received oral
hypoglycemic drugs, 15% received insulin, and the rest
were given combination therapy (tablets plus insulin).
The mean duration of diabetes mellitus in these patients
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was 9 ± 6 years (range, 0.08–36 years). The duration of
diabetes based on median and quantitative distribution
was ≤ 7.5 years in 50.6% of them and > 7.5 years in the
remaining. Mean fasting blood sugar level was 176 ±
56 mg/dL (range, 73–326 mg/dL), 2-hour postpran-
dial blood sugar level was 246 ± 91 mg/dL (range,
52–553 mg/dL) and mean glycosylated hemoglobin level
was 8.9% ± 2% (range, 3.2–16%). Regarding educational
level, 61.9% of our patients were illiterate or had
incomplete primary school education, and 38.1% were
educated. The subjects were mainly housewives
(92.5%), and the rest were working women. There was
sexual activity in 86.3% of the cases, and none in 13.7%
of the cases. Twenty-one percent of our patients had a
history of allergy (rhinitis, sinusitis or atopic dermatitis)
(Table 1).
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Table 1. Frequency distribution of clinical vaginitis, infectious culture, Candida culture among 160 diabetic women based 
on influencing factors
Variable Total
Clinical vaginitis, Infectious culture, Positive Candida culture,
n (%) n (%) n (%)
Age
≤ 45 years 42 31 (73.8) 16 (38.1) 5 (11.9)
> 45 years 118 82 (69.5) 33 (28) 9 (7.6)
Occupation
Working 12 10 (83.3) 5 (41.7) 3 (25)
Housewife 148 103 (69.6) 44 (29.7) 11 (7.4)
Education
Illiterate, incomplete 99 71 (71.7) 24 (24.2)* 5 (5.1)*
primary school
Literate 61 42 (68.9) 25 (41) 9 (14.8)
Diabetes mellitus
Type II 151 106 (70.2) 45 (29.8) 13 (8.6)
Type I 9 7 (77.8) 4 (44.4) 1 (11.1)
Duration of diabetes mellitus
≤ 7.5 years 81 60 (74.1) 31 (38.3)* 9 (11.1)
> 7.5 years 79 53 (67.1) 18 (22.8) 5 (6.3)
Treatment
Insulin 24 17 (70.8) 9 (37.5) 3 (12.5)
Oral hypoglycemic 136 96 (70.6) 40 (29.4) 11 (8.1)
drug or combination
therapy
Fasting blood sugar
< 200 mg/dL 115 80 (69.6) 29 (25.2)* 7 (6.1)
≥ 200 mg/dL 45 33 (73.3) 20 (44.4) 7 (15.6)
Glycosylated hemoglobin
< 7% 27 20 (74.1) 9 (33.3) 2 (7.4)
≥ 7% 113 83 (73.5) 34 (30.1) 8 (7.1)
History of allergy
Yes 34 23 (67.6) 4 (11.8)* 3 (8.8)
No 126 90 (71.4) 45 (35.7) 11 (8.7)
Genital hygiene
Satisfactory 131 93 (71) 38 (29) 13 (9.9)
Moderate or 29 20 (69) 11 (37.9) 1 (3.4)
unsatisfactory
Sexual relationship
Yes 138 102 (73.9)* 37 (26.8)* 13 (9.4)
No 22 11 (50) 12 (54.5) 1 (4.5)
*p ≤ 0.05 by Fisher’s exact test.
The Figure shows the relationship between fasting
blood sugar and prevalence of vaginitis and positive
culture. Clinical vaginitis and Candida vaginitis were
positive in 71% (113/160) and 12.5% (20/160) of the
patients, respectively.
In total, microscopic findings for Candida were pos-
itive in 12 patients, of whom two had Candida vaginitis.
There were no significant statistical differences be-
tween them (p = 0.648). Vaginal culture was positive
for Candida in two patients who had positive smear for
Candida (p = 0.000). The prevalence of Candida vaginitis
together with positive culture was 2.6% (4/160). After
including the 10 patients with positive Candida culture
together with other clinical vaginitis, overall prevalence
of Candida vaginitis based on culture was 8.8% (14/160)
(Table 2). Genital hygiene (cleanliness, evacuation of
the bladder after intercourse, and drying the genital
region after intercourse) was satisfactory, moderate and
poor in 82%, 17% and 1% of the patients, respectively
(Table 1).
Discussion
In the present study, we did not find a significant statis-
tical difference or relationship between positive vagi-
nal Candida culture and type of diabetes mellitus, age,
glycosylated hemoglobin, duration of diabetes melli-
tus, history of allergy, occupation, genital hygiene and
vaginal intercourse. Diabetes mellitus has long been
considered as one of the factors causing Candida vagini-
tis [10,11]. Different studies showed that symptomatic
infection is more common in women with diabetes
than in the normal population [10,11]. The prevalence
ranged from around 7% to more than 50% [12–14],
and most of which was attributed to Candida albicans
[15,16]. In our study, the prevalences of Candida vagini-
tis based on clinical findings and culture were 12.5%
and 8.8%, respectively. Culture of vaginal discharge
revealed that the Candida group was responsible for
2.6% and 8.8% of Candida vaginitis and total vaginitis,
respectively. In other words, Candida was shown after
culture of vaginal discharge from patients who had
colonization of Candida but did not have Candida vagini-
tis and Candida on microscopic examination (Table 2).
Nonetheless, during the last decade, there have been
reports on increasing non-albicans species [17]. Two
specialized clinics reported that the prevalence of vul-
vovaginitis caused by non-albicans species is around
10–20%, with Candida glabrata dominating [18,19].
Sobel et al [17] stated that the probable causes of
higher non-albicans species: the short duration of use
for oral or local anti-Candida regimens; widespread use
of over-the-counter antifungal agents, most of which
are used incorrectly or inadequately; and the prolonged
use of antifungal compounds for the prevention of
recurrent vulvovaginitis, which further intensifies the
problem.
There is the basic problem of vulvovaginitis in women
with uncontrolled blood glucose levels. The control of
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Table 2. Frequency distribution of culture for Candida from vaginal discharge based on presence of vaginitis and microscopic
examination
Variable
Positive Candida culture, Negative Candida culture, Total, 
p
n (%) n (%) n (%)
Clinical Candida vaginitis with 2 (100) 0 (0) 2 (1.3) 0.007
positive smear for Candida
Clinical Candida vaginitis with 2 (11.1) 16 (88.9) 18 (11.3) 0.660
negative smear for Candida
Negative clinical Candida vaginitis with 5 (50) 5 (50) 10 (6.3) 0.000
positive smear for Candida
Negative clinical Candida vaginitis with 5 (3.8) 125 (96.2) 130 (81.3) 0.000
negative smear for Candida
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Figure. Relationship between fasting blood sugar (FBS)
quartile ranges and percentage of subjects with vaginitis,
microscopic findings of Candida, and positive vaginal culture
for Candida species.
blood glucose levels and a suitable antifungal therapy
play an important role in controlling vaginal Candida
infection in diabetic women [12]. In a study of 241
diabetic women, a significant statistical relationship
existed between overall prevalence of vaginal infec-
tions (bacterial and fungal) and mean blood glucose
level [20]. Also, it was suggested that glucose levels be
maintained below 200 mg/dL to avoid dehydration,
caloric loss and glycosuria and to reduce the risk of
infection [21]. We also found a significant statistical
difference between mean fasting blood sugar and infec-
tious culture of vaginal discharge (p = 0.016) (Table 1
and Figure). We did not find a significant statistical
difference between glycosylated hemoglobin and infec-
tious vaginitis, because acute infections such as vaginitis
often occur during the hyperglycemic state, but glyco-
sylated hemoglobin reflects the mean blood glucose
level over the previous 3 months.
Similar to the study by Mas Martin [22], we also
found that most of the patients with positive vaginal
Candida culture (64%) were older than 45 years. Regard-
ing the high prevalence of Candida vaginitis in repro-
ductive ages [18,23] and our lack of knowledge about
the prevalence of this condition in non-diabetic women
with similar age groups (16–75 years), it is suggested
that further evaluation be conducted to determine the
cause. In any case, the incidence of symptomatic infec-
tion is high among reproductive ages (18–44 years)
[24]. Although it was reported that allergic rhinitis and
recurrent Candida vaginitis were present concurrently in
70% of patients [8], we did not find any relationship
between Candida or non-Candida vaginitis and past his-
tory of allergy (sinusitis, rhinitis or atopic dermatitis).
According to our results, there was significant statis-
tical difference between educational level and infectious
or positive vaginal Candida culture. Based on previous
studies [25–28], it is possible that educated women
have knowledge about vaginal conditions or have had
past experience of vaginal symptoms with or without a
gynecologic examination, resulting in their self-diagnosis
or self-treatment. Other factors involved in the patho-
genesis of Candida vulvovaginitis include lifestyle fac-
tors. Although vulvovaginal candidiasis is more frequent
among sexually active women (during the second decade
of life) [24], it is not considered as a sexually transmit-
ted disease [17]. Candida accounts for 20–50% of the
normal vaginal flora of asymptomatic healthy women
[29], and Candida vaginitis can even occur in single
women. Naturally, Candida is transmitted through vagi-
nal sexual intercourse, as well as other modes of sexual
contact [19,30].
There is controversy about the frequency of sexual
intercourse as a risk factor of vaginitis [19,24]. However,
some studies showed that oral sex increases the inci-
dence of vulvovaginal candidiasis [24,31,32] and that
vaginal intercourse alone cannot change the Candida
colonization rates in the vagina [33].
To conclude, our study showed that fungi were not
the cause of infection in more than 50% of the samples
examined in the laboratory. On the other hand, defi-
nite diagnosis would be defined by positive culture. So,
antifungal therapy should be withdrawn in patients
with positive culture for vaginitis, with or without pre-
senting signs of Candida vaginitis, especially in those
with risk factors such as diabetes mellitus. It is impor-
tant, because less attention to that may lead to vulvo-
vaginitis [34–38]. We suggest the use of microscopic
examination plus culture of vaginal discharge to diag-
nose vulvovaginal candidiasis, especially in hyperglycemic
women. Considering the various factors involved in
Candida vaginitis, such as oral contraceptive pill, syn-
thetic underwear and our study limitations, our results
would have been more reliable if the study had been
performed on a larger scale and for a longer duration.
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